2009-02-11 02:08:03 -
Mead Johnson Nutrition Company today announced that its initial public offering of Class A common stock has been priced at $24.00 per share. The size of the offering was increased to 30 million shares from the initial size of 25 million shares.
The shares are scheduled to begin trading tomorrow, February 11, 2009, on the New York Stock Exchange under the ticker symbol "MJN". The underwriters have a 30-day option to purchase up to an additional 4.5 million shares to cover over-allotments, if any. The company noted that net proceeds of approximately $680 million would be used to repay intercompany obligations.
Citi, Morgan Stanley, Banc of America Securities LLC, Credit Suisse and J.P. Morgan are acting
as joint book-running managers for the offering. The public offering is being made by means of a prospectus, copies of which may be obtained from:
- Citigroup Global Markets Inc., Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, New York 11220, Attention: Prospectus Department, telephone (800) 831-9146, or by e-mailing
batprospectusdept@citi.com.
- Morgan Stanley & Co. Incorporated, 180 Varick Street, 2nd Floor, New York, New York, 10014, Attention: Prospectus Department, telephone (866) 718-1649, or by e-mailing
prospectus@morganstanley.com.
A registration statement relating to shares of Class A common stock of Mead Johnson has been declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Mead Johnson
Mead Johnson develops, manufactures, markets and distributes more than 70 products in 50 markets worldwide primarily under the "Enfa" family of brands, including Enfamil® infant formula.
For Mead Johnson Nutrition:
Investor:
Kathryn Chieger, 847-804-9896 (cell)
kathryn.chieger@mjn.com
or
Media:
Pete Paradossi, 812-431-3369 (cell)
pete.paradossi@mjn.com
or
Mike Doyle, 917-608-3059 (cell)
mike.doyle@emanatepr.com 
